Becton, Dickinson and Company (BVMF:B1DX34)

Market Cap	254.20B -40.0%
Revenue (ttm)	120.76B +6.2%
Net Income	9.68B +1.7%
EPS	33.74 +3.1%
Shares Out	n/a
PE Ratio	26.27
Forward PE	13.61
Dividend	3.08 (1.47%)
Ex-Dividend Date	Dec 5, 2025

Volume	n/a
Average Volume	15
Open	209.04
Previous Close	209.04
Day's Range	209.04 - 209.04
52-Week Range	183.35 - 280.42
Beta	0.45
RSI	49.13
Earnings Date	Feb 9, 2026

About BVMF:B1DX34

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, va...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1897
• Employees: 72,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: B1DX34

Financial Performance

In fiscal year 2025, BVMF:B1DX34's revenue was $21.84 billion, an increase of 8.24% compared to the previous year's $20.18 billion. Earnings were $1.68 billion, a decrease of -1.58%.

Financial numbers in USD